EDC4_HUMAN - dbPTM
EDC4_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID EDC4_HUMAN
UniProt AC Q6P2E9
Protein Name Enhancer of mRNA-decapping protein 4
Gene Name EDC4
Organism Homo sapiens (Human).
Sequence Length 1401
Subcellular Localization Cytoplasm, P-body . Nucleus .
Protein Description In the process of mRNA degradation, seems to play a role in mRNA decapping. Component of a complex containing DCP2 and DCP1A which functions in decapping of ARE-containing mRNAs. Promotes complex formation between DCP1A and DCP2. Enhances the catalytic activity of DCP2 (in vitro)..
Protein Sequence MASCASIDIEDATQHLRDILKLDRPAGGPSAESPRPSSAYNGDLNGLLVPDPLCSGDSTSANKTGLRTMPPINLQEKQVICLSGDDSSTCIGILAKEVEIVASSDSSISSKARGSNKVKIQPVAKYDWEQKYYYGNLIAVSNSFLAYAIRAANNGSAMVRVISVSTSERTLLKGFTGSVADLAFAHLNSPQLACLDEAGNLFVWRLALVNGKIQEEILVHIRQPEGTPLNHFRRIIWCPFIPEESEDCCEESSPTVALLHEDRAEVWDLDMLRSSHSTWPVDVSQIKQGFIVVKGHSTCLSEGALSPDGTVLATASHDGYVKFWQIYIEGQDEPRCLHEWKPHDGRPLSCLLFCDNHKKQDPDVPFWRFLITGADQNRELKMWCTVSWTCLQTIRFSPDIFSSVSVPPSLKVCLDLSAEYLILSDVQRKVLYVMELLQNQEEGHACFSSISEFLLTHPVLSFGIQVVSRCRLRHTEVLPAEEENDSLGADGTHGAGAMESAAGVLIKLFCVHTKALQDVQIRFQPQLNPDVVAPLPTHTAHEDFTFGESRPELGSEGLGSAAHGSQPDLRRIVELPAPADFLSLSSETKPKLMTPDAFMTPSASLQQITASPSSSSSGSSSSSSSSSSSLTAVSAMSSTSAVDPSLTRPPEELTLSPKLQLDGSLTMSSSGSLQASPRGLLPGLLPAPADKLTPKGPGQVPTATSALSLELQEVEPLGLPQASPSRTRSPDVISSASTALSQDIPEIASEALSRGFGSSAPEGLEPDSMASAASALHLLSPRPRPGPELGPQLGLDGGPGDGDRHNTPSLLEAALTQEASTPDSQVWPTAPDITRETCSTLAESPRNGLQEKHKSLAFHRPPYHLLQQRDSQDASAEQSDHDDEVASLASASGGFGTKVPAPRLPAKDWKTKGSPRTSPKLKRKSKKDDGDAAMGSRLTEHQVAEPPEDWPALIWQQQRELAELRHSQEELLQRLCTQLEGLQSTVTGHVERALETRHEQEQRRLERALAEGQQRGGQLQEQLTQQLSQALSSAVAGRLERSIRDEIKKTVPPCVSRSLEPMAGQLSNSVATKLTAVEGSMKENISKLLKSKNLTDAIARAAADTLQGPMQAAYREAFQSVVLPAFEKSCQAMFQQINDSFRLGTQEYLQQLESHMKSRKAREQEAREPVLAQLRGLVSTLQSATEQMAATVAGSVRAEVQHQLHVAVGSLQESILAQVQRIVKGEVSVALKEQQAAVTSSIMQAMRSAAGTPVPSAHLDCQAQQAHILQLLQQGHLNQAFQQALTAADLNLVLYVCETVDPAQVFGQPPCPLSQPVLLSLIQQLASDLGTRTDLKLSYLEEAVMHLDHSDPITRDHMGSVMAQVRQKLFQFLQAEPHNSLGKAARRLSLMLHGLVTPSLP
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
2Acetylation------MASCASIDI
------CCCCCCCCH
25.3119413330
3Phosphorylation-----MASCASIDIE
-----CCCCCCCCHH
23.2928122231
6Phosphorylation--MASCASIDIEDAT
--CCCCCCCCHHHHH
25.7225159151
13PhosphorylationSIDIEDATQHLRDIL
CCCHHHHHHHHHHHH
28.9226552605
21UbiquitinationQHLRDILKLDRPAGG
HHHHHHHHCCCCCCC
48.9929967540
30PhosphorylationDRPAGGPSAESPRPS
CCCCCCCCCCCCCCC
48.2023401153
33PhosphorylationAGGPSAESPRPSSAY
CCCCCCCCCCCCCCC
26.4029255136
37PhosphorylationSAESPRPSSAYNGDL
CCCCCCCCCCCCCCC
28.9625159151
38PhosphorylationAESPRPSSAYNGDLN
CCCCCCCCCCCCCCC
37.1430576142
40PhosphorylationSPRPSSAYNGDLNGL
CCCCCCCCCCCCCCE
22.9430576142
55PhosphorylationLVPDPLCSGDSTSAN
ECCCCCCCCCCCCCC
54.0020068231
58PhosphorylationDPLCSGDSTSANKTG
CCCCCCCCCCCCCCC
27.9920068231
59PhosphorylationPLCSGDSTSANKTGL
CCCCCCCCCCCCCCC
36.2820068231
60PhosphorylationLCSGDSTSANKTGLR
CCCCCCCCCCCCCCC
33.5225159151
63UbiquitinationGDSTSANKTGLRTMP
CCCCCCCCCCCCCCC
43.6229967540
64PhosphorylationDSTSANKTGLRTMPP
CCCCCCCCCCCCCCC
41.0523312004
103PhosphorylationKEVEIVASSDSSISS
EEEEEEECCCCCCCC
24.6320068231
104PhosphorylationEVEIVASSDSSISSK
EEEEEECCCCCCCCC
31.6020068231
106PhosphorylationEIVASSDSSISSKAR
EEEECCCCCCCCCCC
31.3620068231
107PhosphorylationIVASSDSSISSKARG
EEECCCCCCCCCCCC
31.3220068231
109PhosphorylationASSDSSISSKARGSN
ECCCCCCCCCCCCCC
27.9520068231
110PhosphorylationSSDSSISSKARGSNK
CCCCCCCCCCCCCCC
28.7620068231
111UbiquitinationSDSSISSKARGSNKV
CCCCCCCCCCCCCCC
35.0032015554
119UbiquitinationARGSNKVKIQPVAKY
CCCCCCCEEEECEEC
36.9129967540
125AcetylationVKIQPVAKYDWEQKY
CEEEECEECCHHHCE
43.9319608861
125UbiquitinationVKIQPVAKYDWEQKY
CEEEECEECCHHHCE
43.9322817900
125 (in isoform 1)Ubiquitination-43.9321890473
126PhosphorylationKIQPVAKYDWEQKYY
EEEECEECCHHHCEE
19.2922817900
147PhosphorylationVSNSFLAYAIRAANN
ECHHHHHHHHHHHHC
12.5222817900
165PhosphorylationMVRVISVSTSERTLL
EEEEEEEECCCCHHH
21.3022210691
166PhosphorylationVRVISVSTSERTLLK
EEEEEEECCCCHHHC
32.2422210691
170PhosphorylationSVSTSERTLLKGFTG
EEECCCCHHHCCCCC
32.1822210691
287UbiquitinationPVDVSQIKQGFIVVK
CCCHHHCCCCEEEEE
36.41-
359UbiquitinationLFCDNHKKQDPDVPF
EEECCCCCCCCCCCH
53.0029967540
385PhosphorylationRELKMWCTVSWTCLQ
CEEEHHHEEEHHHHH
11.3224043423
387PhosphorylationLKMWCTVSWTCLQTI
EEHHHEEEHHHHHHH
9.8724043423
389PhosphorylationMWCTVSWTCLQTIRF
HHHEEEHHHHHHHCC
8.8824043423
393PhosphorylationVSWTCLQTIRFSPDI
EEHHHHHHHCCCCCH
10.9424043423
405PhosphorylationPDIFSSVSVPPSLKV
CCHHHCCCCCCCHHH
30.74-
409PhosphorylationSSVSVPPSLKVCLDL
HCCCCCCCHHHHHHH
34.4520068231
475PhosphorylationSRCRLRHTEVLPAEE
HCCCCCCCEEECCHH
22.7320068231
486PhosphorylationPAEEENDSLGADGTH
CCHHHCCCCCCCCCC
40.0423401153
492PhosphorylationDSLGADGTHGAGAME
CCCCCCCCCCHHHHH
20.0628192239
500PhosphorylationHGAGAMESAAGVLIK
CCHHHHHHHHHHHHH
15.4423401153
514AcetylationKLFCVHTKALQDVQI
HHHHHHCCHHCCCHH
32.0226051181
537PhosphorylationDVVAPLPTHTAHEDF
CCEECCCCCCCCCCC
39.2726330541
539PhosphorylationVAPLPTHTAHEDFTF
EECCCCCCCCCCCCC
31.9926330541
545PhosphorylationHTAHEDFTFGESRPE
CCCCCCCCCCCCCCC
42.9526074081
549PhosphorylationEDFTFGESRPELGSE
CCCCCCCCCCCCCCC
54.2226074081
555PhosphorylationESRPELGSEGLGSAA
CCCCCCCCCCCCHHC
40.9129255136
560PhosphorylationLGSEGLGSAAHGSQP
CCCCCCCHHCCCCCC
27.5929255136
565PhosphorylationLGSAAHGSQPDLRRI
CCHHCCCCCCCHHHH
28.7729255136
583PhosphorylationPAPADFLSLSSETKP
CCCCCHHCCCCCCCC
26.6324972180
585PhosphorylationPADFLSLSSETKPKL
CCCHHCCCCCCCCCC
23.8125159151
586PhosphorylationADFLSLSSETKPKLM
CCHHCCCCCCCCCCC
55.3626055452
588PhosphorylationFLSLSSETKPKLMTP
HHCCCCCCCCCCCCC
55.3725159151
589AcetylationLSLSSETKPKLMTPD
HCCCCCCCCCCCCCC
35.7826051181
589UbiquitinationLSLSSETKPKLMTPD
HCCCCCCCCCCCCCC
35.78-
594PhosphorylationETKPKLMTPDAFMTP
CCCCCCCCCCCCCCC
28.5826074081
613PhosphorylationQQITASPSSSSSGSS
HHHHCCCCCCCCCCC
40.12-
621PhosphorylationSSSSGSSSSSSSSSS
CCCCCCCCCCCCCCC
35.62-
622PhosphorylationSSSGSSSSSSSSSSS
CCCCCCCCCCCCCCC
35.87-
623PhosphorylationSSGSSSSSSSSSSSL
CCCCCCCCCCCCCCC
35.87-
624PhosphorylationSGSSSSSSSSSSSLT
CCCCCCCCCCCCCCH
35.87-
640O-linked_GlycosylationVSAMSSTSAVDPSLT
HHCCCCCCCCCHHHC
28.39OGP
645PhosphorylationSTSAVDPSLTRPPEE
CCCCCCHHHCCCCHH
37.6021406692
647PhosphorylationSAVDPSLTRPPEELT
CCCCHHHCCCCHHCC
45.5321406692
654PhosphorylationTRPPEELTLSPKLQL
CCCCHHCCCCCCEEE
28.5926074081
656PhosphorylationPPEELTLSPKLQLDG
CCHHCCCCCCEEECC
18.1126657352
664PhosphorylationPKLQLDGSLTMSSSG
CCEEECCCEEECCCC
21.9726055452
666PhosphorylationLQLDGSLTMSSSGSL
EEECCCEEECCCCCC
19.3927732954
668PhosphorylationLDGSLTMSSSGSLQA
ECCCEEECCCCCCCC
19.0022199227
669PhosphorylationDGSLTMSSSGSLQAS
CCCEEECCCCCCCCC
28.0922199227
670PhosphorylationGSLTMSSSGSLQASP
CCEEECCCCCCCCCC
25.7022199227
672PhosphorylationLTMSSSGSLQASPRG
EEECCCCCCCCCCCC
21.1822199227
676PhosphorylationSSGSLQASPRGLLPG
CCCCCCCCCCCCCCC
11.3625159151
691AcetylationLLPAPADKLTPKGPG
CCCCCHHHCCCCCCC
57.2625953088
693PhosphorylationPAPADKLTPKGPGQV
CCCHHHCCCCCCCCC
28.7930266825
702PhosphorylationKGPGQVPTATSALSL
CCCCCCCCHHHEEEE
43.6530278072
704PhosphorylationPGQVPTATSALSLEL
CCCCCCHHHEEEEEE
19.6028176443
705PhosphorylationGQVPTATSALSLELQ
CCCCCHHHEEEEEEE
25.4228176443
708PhosphorylationPTATSALSLELQEVE
CCHHHEEEEEEEECC
21.3630278072
723PhosphorylationPLGLPQASPSRTRSP
CCCCCCCCCCCCCCH
20.4029255136
725PhosphorylationGLPQASPSRTRSPDV
CCCCCCCCCCCCHHH
43.7329255136
727PhosphorylationPQASPSRTRSPDVIS
CCCCCCCCCCHHHHH
39.5822167270
729PhosphorylationASPSRTRSPDVISSA
CCCCCCCCHHHHHHH
25.4919664994
734PhosphorylationTRSPDVISSASTALS
CCCHHHHHHHHHHHH
21.5022167270
735PhosphorylationRSPDVISSASTALSQ
CCHHHHHHHHHHHHC
18.3426846344
737PhosphorylationPDVISSASTALSQDI
HHHHHHHHHHHHCCH
19.0326846344
738PhosphorylationDVISSASTALSQDIP
HHHHHHHHHHHCCHH
31.1926846344
741PhosphorylationSSASTALSQDIPEIA
HHHHHHHHCCHHHHH
24.2826846344
749PhosphorylationQDIPEIASEALSRGF
CCHHHHHHHHHHCCC
29.1223927012
753PhosphorylationEIASEALSRGFGSSA
HHHHHHHHCCCCCCC
37.0923927012
758PhosphorylationALSRGFGSSAPEGLE
HHHCCCCCCCCCCCC
22.5225850435
759PhosphorylationLSRGFGSSAPEGLEP
HHCCCCCCCCCCCCC
48.5025850435
768PhosphorylationPEGLEPDSMASAASA
CCCCCCCHHHHHHHH
27.2827794612
771PhosphorylationLEPDSMASAASALHL
CCCCHHHHHHHHHHH
18.7427794612
774PhosphorylationDSMASAASALHLLSP
CHHHHHHHHHHHHCC
30.9526055452
780PhosphorylationASALHLLSPRPRPGP
HHHHHHHCCCCCCCC
25.8129255136
807PhosphorylationGDGDRHNTPSLLEAA
CCCCCCCCHHHHHHH
14.2326055452
809PhosphorylationGDRHNTPSLLEAALT
CCCCCCHHHHHHHHH
43.4821712546
816PhosphorylationSLLEAALTQEASTPD
HHHHHHHHHCCCCCC
21.4520873877
820PhosphorylationAALTQEASTPDSQVW
HHHHHCCCCCCHHHC
39.4625159151
821PhosphorylationALTQEASTPDSQVWP
HHHHCCCCCCHHHCC
37.8625159151
824PhosphorylationQEASTPDSQVWPTAP
HCCCCCCHHHCCCCC
28.0420873877
829PhosphorylationPDSQVWPTAPDITRE
CCHHHCCCCCCCCHH
34.8020068231
834PhosphorylationWPTAPDITRETCSTL
CCCCCCCCHHHHHHH
29.8120068231
837PhosphorylationAPDITRETCSTLAES
CCCCCHHHHHHHHHC
14.4123898821
839PhosphorylationDITRETCSTLAESPR
CCCHHHHHHHHHCCC
33.6025159151
840PhosphorylationITRETCSTLAESPRN
CCHHHHHHHHHCCCC
31.9430266825
844PhosphorylationTCSTLAESPRNGLQE
HHHHHHHCCCCCHHH
24.4519664994
855PhosphorylationGLQEKHKSLAFHRPP
CHHHHHHHHHHCCCC
25.3428348404
863PhosphorylationLAFHRPPYHLLQQRD
HHHCCCCHHHHCCCC
14.0528796482
871PhosphorylationHLLQQRDSQDASAEQ
HHHCCCCCCCCCHHH
31.9523927012
875PhosphorylationQRDSQDASAEQSDHD
CCCCCCCCHHHCCCH
40.4020201521
879PhosphorylationQDASAEQSDHDDEVA
CCCCHHHCCCHHHHH
28.5520201521
887PhosphorylationDHDDEVASLASASGG
CCHHHHHHHHHHCCC
29.6423927012
887 (in isoform 2)Ubiquitination-29.6421906983
890PhosphorylationDEVASLASASGGFGT
HHHHHHHHHCCCCCC
28.4130278072
892PhosphorylationVASLASASGGFGTKV
HHHHHHHCCCCCCCC
36.6323927012
897PhosphorylationSASGGFGTKVPAPRL
HHCCCCCCCCCCCCC
26.9723927012
907AcetylationPAPRLPAKDWKTKGS
CCCCCCCCCCCCCCC
63.2825953088
911PhosphorylationLPAKDWKTKGSPRTS
CCCCCCCCCCCCCCC
36.0620363803
914PhosphorylationKDWKTKGSPRTSPKL
CCCCCCCCCCCCHHH
16.8628102081
917PhosphorylationKTKGSPRTSPKLKRK
CCCCCCCCCHHHCCC
53.4130576142
918PhosphorylationTKGSPRTSPKLKRKS
CCCCCCCCHHHCCCC
22.7128102081
925PhosphorylationSPKLKRKSKKDDGDA
CHHHCCCCCCCCCCC
49.3121406692
926UbiquitinationPKLKRKSKKDDGDAA
HHHCCCCCCCCCCCC
64.3624816145
936PhosphorylationDGDAAMGSRLTEHQV
CCCCCHHCCCCCCCC
15.8421406692
965MethylationQRELAELRHSQEELL
HHHHHHHHHCHHHHH
20.93-
967PhosphorylationELAELRHSQEELLQR
HHHHHHHCHHHHHHH
32.6220873877
977PhosphorylationELLQRLCTQLEGLQS
HHHHHHHHHHHHHHH
40.5624719451
1015MethylationALAEGQQRGGQLQEQ
HHHHHHHHHHHHHHH
43.23-
1042PhosphorylationVAGRLERSIRDEIKK
HHHHHHHHHHHHHHH
16.7623898821
1049UbiquitinationSIRDEIKKTVPPCVS
HHHHHHHHHCCCCHH
61.4924816145
1050PhosphorylationIRDEIKKTVPPCVSR
HHHHHHHHCCCCHHH
32.9927470641
1058PhosphorylationVPPCVSRSLEPMAGQ
CCCCHHHCCCCCCHH
29.5823612710
1062SulfoxidationVSRSLEPMAGQLSNS
HHHCCCCCCHHCHHH
4.8321406390
1067PhosphorylationEPMAGQLSNSVATKL
CCCCHHCHHHHHHHH
21.1220068231
1069PhosphorylationMAGQLSNSVATKLTA
CCHHCHHHHHHHHHH
15.1120068231
1072PhosphorylationQLSNSVATKLTAVEG
HCHHHHHHHHHHCCC
25.1620068231
1075PhosphorylationNSVATKLTAVEGSMK
HHHHHHHHHCCCHHH
30.1622673903
1080PhosphorylationKLTAVEGSMKENISK
HHHHCCCHHHHHHHH
17.1122673903
1082UbiquitinationTAVEGSMKENISKLL
HHCCCHHHHHHHHHH
49.67-
1087AcetylationSMKENISKLLKSKNL
HHHHHHHHHHHCCCH
54.7825953088
1087MalonylationSMKENISKLLKSKNL
HHHHHHHHHHHCCCH
54.7826320211
1087UbiquitinationSMKENISKLLKSKNL
HHHHHHHHHHHCCCH
54.7829967540
10922-HydroxyisobutyrylationISKLLKSKNLTDAIA
HHHHHHCCCHHHHHH
55.15-
1092MalonylationISKLLKSKNLTDAIA
HHHHHHCCCHHHHHH
55.1526320211
1092UbiquitinationISKLLKSKNLTDAIA
HHHHHHCCCHHHHHH
55.1529967540
1148PhosphorylationFRLGTQEYLQQLESH
HHHCHHHHHHHHHHH
10.4528555341
1154PhosphorylationEYLQQLESHMKSRKA
HHHHHHHHHHHHHHH
37.1625159151
1157AcetylationQQLESHMKSRKAREQ
HHHHHHHHHHHHHHH
41.5025953088
1157UbiquitinationQQLESHMKSRKAREQ
HHHHHHHHHHHHHHH
41.5023000965
1157 (in isoform 1)Ubiquitination-41.5021890473
1158PhosphorylationQLESHMKSRKAREQE
HHHHHHHHHHHHHHH
31.2928857561
1160UbiquitinationESHMKSRKAREQEAR
HHHHHHHHHHHHHHH
59.9123000965
1248PhosphorylationSIMQAMRSAAGTPVP
HHHHHHHHHCCCCCC
14.9126657352
1252PhosphorylationAMRSAAGTPVPSAHL
HHHHHCCCCCCCHHH
19.1826657352
1256PhosphorylationAAGTPVPSAHLDCQA
HCCCCCCCHHHHHHH
28.6726074081
1345SulfoxidationSYLEEAVMHLDHSDP
HHHHHHHHCCCCCCC
3.1530846556
1368AcetylationVMAQVRQKLFQFLQA
HHHHHHHHHHHHHHC
40.4826051181
1368UbiquitinationVMAQVRQKLFQFLQA
HHHHHHHHHHHHHHC
40.48-
1380PhosphorylationLQAEPHNSLGKAARR
HHCCCCCHHHHHHHH
35.1522617229
1383UbiquitinationEPHNSLGKAARRLSL
CCCCHHHHHHHHHHH
44.13-
1389PhosphorylationGKAARRLSLMLHGLV
HHHHHHHHHHHCCCC
15.2128450419
1399PhosphorylationLHGLVTPSLP-----
HCCCCCCCCC-----
43.8627251275

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
107SPhosphorylationKinaseIKKBO14920
PSP
405SPhosphorylationKinaseIKKBO14920
PSP
583SPhosphorylationKinaseIKKBO14920
PSP
855SPhosphorylationKinaseIKKBO14920
PSP

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of EDC4_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of EDC4_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
DCP2_HUMANDCP2physical
21672539
DCP1B_HUMANDCP1Bphysical
21672539
DCP1A_HUMANDCP1Aphysical
16364915
DCP2_HUMANDCP2physical
16364915
FBLN1_HUMANFBLN1physical
21988832
GIT2_HUMANGIT2physical
21988832
YTDC1_HUMANYTHDC1physical
21988832
ABCF1_HUMANABCF1physical
22863883
NELFB_HUMANNELFBphysical
22863883
DDX1_HUMANDDX1physical
22863883
DIM1_HUMANDIMT1physical
22863883
IF2B3_HUMANIGF2BP3physical
22863883
ILF2_HUMANILF2physical
22863883
NMT1_HUMANNMT1physical
22863883
RFC4_HUMANRFC4physical
22863883
DCP1A_HUMANDCP1Aphysical
24778252
DCP2_HUMANDCP2physical
24778252

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of EDC4_HUMAN

loading...

Related Literatures of Post-Translational Modification
Acetylation
ReferencePubMed
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT SER-6; SER-725; SER-844; SER-875; SER-879 ANDSER-887, AND MASS SPECTROMETRY.
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions.";
Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.;
Science 325:834-840(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-125, AND MASS SPECTROMETRY.
Phosphorylation
ReferencePubMed
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions.";
Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.;
Sci. Signal. 2:RA46-RA46(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-676; THR-693; SER-725;SER-729; SER-741; SER-875; SER-879 AND SER-892, AND MASS SPECTROMETRY.
"Large-scale proteomics analysis of the human kinome.";
Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.;
Mol. Cell. Proteomics 8:1751-1764(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-723; SER-725; THR-727;SER-729; SER-871; SER-875 AND SER-879, AND MASS SPECTROMETRY.
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT SER-6; SER-725; SER-844; SER-875; SER-879 ANDSER-887, AND MASS SPECTROMETRY.
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-693; SER-725; SER-809;THR-821; SER-844 AND SER-879, AND MASS SPECTROMETRY.
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle.";
Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.;
Mol. Cell 31:438-448(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-693; SER-723; SER-729;SER-780 AND SER-871, AND MASS SPECTROMETRY.
"Combining protein-based IMAC, peptide-based IMAC, and MudPIT forefficient phosphoproteomic analysis.";
Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,Yates J.R. III;
J. Proteome Res. 7:1346-1351(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-723; SER-725; THR-727;SER-729 AND SER-734, AND MASS SPECTROMETRY.
"ATM and ATR substrate analysis reveals extensive protein networksresponsive to DNA damage.";
Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.;
Science 316:1160-1166(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-729 AND SER-741, ANDMASS SPECTROMETRY.
"Phosphoproteome analysis of the human mitotic spindle.";
Nousiainen M., Sillje H.H.W., Sauer G., Nigg E.A., Koerner R.;
Proc. Natl. Acad. Sci. U.S.A. 103:5391-5396(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1067 AND THR-1072, ANDMASS SPECTROMETRY.
"A probability-based approach for high-throughput proteinphosphorylation analysis and site localization.";
Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
Nat. Biotechnol. 24:1285-1292(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-844, AND MASSSPECTROMETRY.
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks.";
Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.;
Cell 127:635-648(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-729, AND MASSSPECTROMETRY.
"Improved titanium dioxide enrichment of phosphopeptides from HeLacells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra.";
Yu L.-R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.;
J. Proteome Res. 6:4150-4162(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-693, AND MASSSPECTROMETRY.

TOP